Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 146

1.

Characterization of chemical constituents in Scutellaria baicalensis with antiandrogenic and growth-inhibitory activities toward prostate carcinoma.

Bonham M, Posakony J, Coleman I, Montgomery B, Simon J, Nelson PS.

Clin Cancer Res. 2005 May 15;11(10):3905-14.

2.

Effects of the herbal extract PC-SPES on microtubule dynamics and paclitaxel-mediated prostate tumor growth inhibition.

Bonham MJ, Galkin A, Montgomery B, Stahl WL, Agus D, Nelson PS.

J Natl Cancer Inst. 2002 Nov 6;94(21):1641-7.

PMID:
12419791
3.

Prevention and management of prostate cancer using PC-SPES: a scientific perspective.

Hsieh TC, Lu X, Chea J, Wu JM.

J Nutr. 2002 Nov;132(11 Suppl):3513S-3517S.

6.
7.

In vitro mechanism of PC SPES.

Chenn S.

Urology. 2001 Aug;58(2 Suppl 1):28-35; discussion 38.

PMID:
11502443
8.

Molecular mechanism of anti-prostate cancer activity of Scutellaria baicalensis extract.

Ye F, Jiang S, Volshonok H, Wu J, Zhang DY.

Nutr Cancer. 2007;57(1):100-10.

PMID:
17516867
9.

Inhibition of cancer cell proliferation and prostaglandin E2 synthesis by Scutellaria baicalensis.

Zhang DY, Wu J, Ye F, Xue L, Jiang S, Yi J, Zhang W, Wei H, Sung M, Wang W, Li X.

Cancer Res. 2003 Jul 15;63(14):4037-43.

10.

Possible mechanism of growth inhibition by Scutellaria baicalensis in an estrogen-responsive mouse tumor cell line.

Murashima T, Katayama H, Shojiro K, Nishizawa Y.

Oncol Rep. 2011 May;25(5):1431-8. doi: 10.3892/or.2011.1196. Epub 2011 Mar 1.

PMID:
21369700
11.

In vitro antitumor mechanisms of various Scutellaria extracts and constituent flavonoids.

Parajuli P, Joshee N, Rimando AM, Mittal S, Yadav AK.

Planta Med. 2009 Jan;75(1):41-8. doi: 10.1055/s-0028-1088364. Epub 2008 Nov 24.

PMID:
19031366
12.
13.
14.

Effects of Scutellaria baicalensis Georgi on macrophage-hepatocyte interaction through cytokines related to growth control of murine hepatocytes.

Wang JY, Chuang HN, Chiu JH, Fu SL, Tsai TH, Tsou AP, Hu CP, Chi CW, Yeh SF, Lui WY, Wu CW, Chou CK.

Exp Biol Med (Maywood). 2006 Apr;231(4):444-55.

PMID:
16565440
15.

Proliferation of estrogen-responsive mouse tumor cell line B-1F stimulated by Saiboku-to, but inhibited by Scutellaria baicalensis, a component of Saiboku-to.

Murashima T, Yamasaki M, Nishizawa Y, Katayama H, Tanigaki Y, Saeki Y, Shojiro K, Nishizawa Y.

Oncol Rep. 2009 Aug;22(2):257-64.

PMID:
19578764
16.

Inhibition of human prostate cancer xenograft growth by 125I labeled triple-helix forming oligonucleotide directed against androgen receptor.

Zhang Y, Ma Y, Lu HP, Gao JH, Liang CS, Liu CZ, Zou JT, Wang HQ.

Chin Med J (Engl). 2008 Nov 20;121(22):2284-9.

PMID:
19080333
17.

Suberoylanilide hydroxamic acid (vorinostat) represses androgen receptor expression and acts synergistically with an androgen receptor antagonist to inhibit prostate cancer cell proliferation.

Marrocco DL, Tilley WD, Bianco-Miotto T, Evdokiou A, Scher HI, Rifkind RA, Marks PA, Richon VM, Butler LM.

Mol Cancer Ther. 2007 Jan;6(1):51-60. Epub 2007 Jan 11.

18.

Gene expression profiling predicts liver responses to a herbal remedy after partial hepatectomy in mice.

Wang JY, Chiu JH, Tsai TH, Tsou AP, Hu CP, Chi CW, Yeh SF, Lui WY, Wu CW, Chou CK.

Int J Mol Med. 2005 Aug;16(2):221-31.

PMID:
16012753
19.

Evolution of the androgen receptor pathway during progression of prostate cancer.

Hendriksen PJ, Dits NF, Kokame K, Veldhoven A, van Weerden WM, Bangma CH, Trapman J, Jenster G.

Cancer Res. 2006 May 15;66(10):5012-20.

20.

Pharmacologic basis for the enhanced efficacy of dutasteride against prostatic cancers.

Xu Y, Dalrymple SL, Becker RE, Denmeade SR, Isaacs JT.

Clin Cancer Res. 2006 Jul 1;12(13):4072-9.

Supplemental Content

Support Center